Skip to main content

Advertisement

SpringerLink
Log in

Epidemiological, clinical, and diagnostic data on intestinal infections with Entamoeba histolytica and Entamoeba dispar among returning travelers

  • Clinical and Epidemiological Study
  • Published:
Infection Aims and scope Submit manuscript

Abstract

Background

Among travelers returning from the tropics, Entamoeba spp. are among the most frequently detected intestinal parasites, mainly the presumable apathogenic E. dispar and the pathogenic E. histolytica.

Methods

Among 5,378 travelers seeking diagnosis and treatment for intestinal infections at the travel clinic of the University of Munich between 2005 and 2009, 103 laboratory-confirmed amebiasis cases were detected. The study compares the results of various diagnostic tests among these patients, analyzes data on co-infections and clinical symptoms, and determines the risk for acquiring amebiasis.

Results

Initial screening tests (stool microscopy, coproantigen enzyme-linked immunosorbent assay [ELISA]) were positive in 82.5 and 93.9%, respectively. Fecal samples from patients with positive screening test results were subjected to polymerase chain reaction (PCR), which detected E. histolytica in 9.7% and E. dispar in 88.3% of the cases. The majority of E. histolytica cases and more than half of the E. dispar cases had intestinal symptoms typical for amebiasis. In 53.4% of the cases, intestinal co-infections were found, mostly Blastocystis hominis (39.8%), Giardia lamblia (10.7%), Campylobacter spp. (4.9%), and Salmonella typhi (2.9%). The risk for travelers to be infected with E. histolytica or E. dispar was highest for destinations in West Africa, East Africa, and South and South-East Asia.

Conclusion

Stool microscopy and coproantigen ELISA are appropriate screening tests for intestinal Entamoeba infections among travelers, but intestinal co-infections are common. PCR is highly recommended as the diagnostic method of choice for the differentiation of Entamoeba spp. The presumable apathogenic E. dispar seems to provoke intestinal symptoms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Walsh JA. Problems in recognition and diagnosis of amebiasis: estimation of the global magnitude of morbidity and mortality. Rev Infect Dis. 1986;8:228–38. Review.

    Article  PubMed  CAS  Google Scholar 

  2. WHO/PAHO/UNESCO. A consultation with experts on amoebiasis. Mexico City, Mexico 28–29 January, 1997. Epidemiol Bull. 1997;18:13–4.

    Google Scholar 

  3. Tannich E, Burchard GD. Amöbiasis und andere Amöbeninfektionen. In: Löscher T, Burchard GD, editors. Tropenmedizin in Klinik und Praxi. Stuttgart: Thieme Verlag; 2010. p. 645.

    Google Scholar 

  4. Ali IK, Hossain MB, Roy S, Ayeh-Kumi PF, Petri WA Jr, Haque R, Clark CG. Entamoeba moshkovskii infections in children, Bangladesh. Emerg Infect Dis. 2003;9:580–4.

    PubMed  CAS  Google Scholar 

  5. Gutiérrez-Cisneros MJ, Cogollos R, López-Vélez R, Martín-Rabadán P, Martínez-Ruiz R, Subirats M, Merino FJ, Fuentes I. Application of real-time PCR for the differentiation of Entamoeba histolytica and E. dispar in cyst-positive faecal samples from 130 immigrants living in Spain. Ann Trop Med Parasitol. 2010;104:145–9.

    Article  PubMed  Google Scholar 

  6. Cavallo JD, Garrabé E. Infectious aetiologies of travelers’ diarrhoea. Med Mal Infect. 2007;37:722–7.

    Article  PubMed  Google Scholar 

  7. Chapman PA. Cryptosporidiosis: recent trends in epidemiology, diagnosis, and treatment. Serodiagn Immunother Infect Dis. 1988;2:311–7.

    Article  Google Scholar 

  8. Garcia LS, Shimizu RY, Bernard CN. Detection of Giardia lamblia, Entamoeba histolytica/Entamoeba dispar, and Cryptosporidium parvum antigens in human fecal specimens using the triage parasite panel enzyme immunoassay. J Clin Microbiol. 2000;38:3337–40.

    PubMed  CAS  Google Scholar 

  9. Paschke C, Apelt N, Fleischmann E, Perona P, Walentiny C, Löscher T, Herbinger KH. Controlled study on enteropathogens in travellers returning from the tropics with and without diarrhoea. Clin Microbiol Infect 2010; [Epub ahead of print].

  10. Clark CG. The evolution of Entamoeba, a cautionary tale. Res Microbiol. 2000;151:599–603.

    Article  PubMed  CAS  Google Scholar 

  11. Farthing MJG, Cevallos AM, Kelly P. Intestinal protozoa. In: Cook GC, editor. Manson’s tropical diseases. Amsterdam: Elsevier and WB Saunders; 2003. p. 1373–410

    Google Scholar 

  12. Haque R, Neville LM, Hahn P, Petri WA Jr. Rapid diagnosis of Entamoeba infection by using Entamoeba and Entamoeba histolytica stool antigen detection kits. J Clin Microbiol. 1995;33:2558–61.

    PubMed  CAS  Google Scholar 

  13. Tannich E. The laboratory diagnosis of Entamoeba histolytica infections. J Lab Med. 2004;28:491–7.

    Google Scholar 

  14. Hiatt RA, Markell EK, Ng E. How many stool examinations are necessary to detect pathogenic intestinal protozoa? Am J Trop Med Hyg. 1995;53:36–9.

    PubMed  CAS  Google Scholar 

  15. Khairnar K, Parija SC. A novel nested multiplex polymerase chain reaction (PCR) assay for differential detection of Entamoeba histolytica, E. moshkovskii and E. dispar DNA in stool samples. BMC Microbiol. 2007;7:47.

    Article  PubMed  Google Scholar 

  16. Huston CD, Haque R, Petri WA Jr. Molecular-based diagnosis of Entamoeba histolytica infection. Expert Rev Mol Med. 1999;22:1–11.

    Google Scholar 

  17. Haque R, Ali IKM, Akther S, Petri WA Jr. Comparison of PCR, isoenzyme analysis, and antigen detection for diagnosis of Entamoeba histolytica infection. J Clin Microbiol. 1998;36:449–52.

    PubMed  CAS  Google Scholar 

  18. Zeehaida M, Wan Nor Amilah WA, Amry AR, Hassan S, Sarimah A, Rahmah N. A study on the usefulness of Techlab Entamoeba histolytica II antigen detection ELISA in the diagnosis of amoebic liver abscess (ALA) at Hospital Universiti Sains Malaysia (HUSM), Kelantan, Malaysia. Trop Biomed. 2008;25:209–16.

    PubMed  CAS  Google Scholar 

  19. Jelinek T, Peyerl G, Löscher T, Nothdurft HD. Evaluation of an antigen-capture enzyme immunoassay for detection of Entamoeba histolytica in stool samples. Eur J Clin Microbiol Infect Dis. 1996;15:752–5.

    Article  PubMed  CAS  Google Scholar 

  20. Pillai DR, Keystone JS, Sheppard DC, MacLean JD, MacPherson DW, Kain KC. Entamoeba histolytica and Entamoeba dispar: epidemiology and comparison of diagnostic methods in a setting of nonendemicity. Clin Infect Dis. 1999;29:1315–8.

    Article  PubMed  CAS  Google Scholar 

  21. el-Hamshary EM, el-Shewy KA, Hegazy MM, Zakaria H. Diagnostic potentials of copro-antigen detection based ELISA, compared to microscopy in intestinal amoebiasis. J Egypt Soc Parasitol. 2004;34:601–10.

    PubMed  Google Scholar 

  22. Gonzalez-Ruiz A, Haque R, Rehman T, Aguirre A, Hall A, Guhl F, Warhurst DC, Miles MA. Diagnosis of amebic dysentery by detection of Entamoeba histolytica fecal antigen by an invasive strain-specific, monoclonal antibody-based enzyme-linked immunosorbent assay. J Clin Microbiol. 1994;32:964–70.

    PubMed  CAS  Google Scholar 

  23. Aguirre A, Warhurst DC, Guhl F, Frame IA. Polymerase chain reaction-solution hybridization enzyme-linked immunoassay (PCR-SHELA) for the differential diagnosis of pathogenic and non-pathogenic Entamoeba histolytica. Trans R Soc Trop Med Hyg. 1995;89:187–8.

    Article  PubMed  CAS  Google Scholar 

  24. Blessmann J, Buss H, Nu PA, Dinh BT, Ngo QT, Van AL, Alla MD, Jackson TF, Ravdin JI, Tannich E. Real-time PCR for detection and differentiation of Entamoeba histolytica and Entamoeba dispar in fecal samples. J Clin Microbiol. 2002;40:4413–7.

    Article  PubMed  CAS  Google Scholar 

  25. Hamzah Z, Petmitr S, Mungthin M, Leelayoova S, Chavalitshewinkoon-Petmitr P. Differential detection of Entamoeba histolytica, Entamoeba dispar, and Entamoeba moshkovskii by a single-round PCR assay. J Clin Microbiol. 2006;44:3196–200.

    Article  PubMed  CAS  Google Scholar 

  26. Parija SC, Khairnar K. Entamoeba moshkovskii and Entamoeba dispar-associated Infections in Pondicherry, India. J Health Popul Nutr. 2005;23:292–5.

    PubMed  Google Scholar 

  27. Roy S, Kabir M, Mondal D, Ali IK, Petri WA Jr, Haque R. Real-time-PCR assay for diagnosis of Entamoeba histolytica infection. J Clin Microbiol. 2005;43:2168–72.

    Article  PubMed  CAS  Google Scholar 

  28. Haque R, Roy S, Siddique A, Mondal U, Rahman SM, Mondal D, Houpt E, Petri WA Jr. Multiplex real-time PCR assay for detection of Entamoeba histolytica, Giardia intestinalis, and Cryptosporidium spp. Am J Trop Med Hyg. 2007;76:713–7.

    PubMed  CAS  Google Scholar 

  29. Leippe M, Ebel S, Schoenberger OL, Horstmann RD, Müller-Eberhard HJ. Pore-forming peptide of pathogenic Entamoeba histolytica. Proc Natl Acad Sci USA. 1991;88:7659–63.

    Article  PubMed  CAS  Google Scholar 

  30. Munford RS, Sheppard PO, O’Hara PJ. Saposin-like proteins (SAPLIP) carry out diverse functions on a common backbone structure. J Lipid Res. 1995;36:1653–63.

    PubMed  CAS  Google Scholar 

  31. Leippe M. Amoebapores. Parasitol Today. 1997;13:178–83.

    Article  PubMed  CAS  Google Scholar 

  32. Nickel R, Ott C, Dandekar T, Leippe M. Pore-forming peptides of Entamoeba dispar. Similarity and divergence to amoebapores in structure, expression and activity. Eur J Biochem. 1999;265:1002–7.

    Article  PubMed  CAS  Google Scholar 

  33. Ximénez C, Cerritos R, Rojas L, Dolabella S, Morán P, Shibayama M, González E, Valadez A, Hernández E, Valenzuela O, Limón A, Partida O, Silva EF. Human amebiasis: breaking the paradigm? Int J Environ Res Public Health. 2010;7:1105–20.

    Article  PubMed  Google Scholar 

  34. Vohra H, Bhatti HS, Ganguly NK, Mahajan RC. Virulence of pathogenic and non-pathogenic zymodemes of Entamoeba histolytica (Indian strains) in guinea-pigs. Trans R Soc Trop Med Hyg. 1989;83:648–50.

    Article  PubMed  CAS  Google Scholar 

  35. Garcia LS. Diagnostic medical parasitology. 4th edn. Washington, DC: ASM Press; 2001.

    Google Scholar 

  36. Hossain A, Bolbol AS, Chowdhury MN, Bakir TM. Indirect haemagglutination (IHA) test in the serodiagnosis of amoebiasis. J Hyg Epidemiol Microbiol Immunol. 1989;33:91–7.

    PubMed  CAS  Google Scholar 

  37. Funke M, Felgner P, Geister R. Quantification of amebae specific antibodies as “Multiple of normal activity (MONA)” with a standardized enzyme immunoassay (EIA). Zentralbl Bakteriol Mikrobiol Hyg A. 1981;251:126–33.

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors thank all of the patients in this study for their cooperation.

Conflict of interest

None of the authors had any conflict of interest.

Author information

Authors and Affiliations

  1. Department of Infectious Diseases and Tropical Medicine, University Hospital, Ludwig-Maximilians University of Munich, Leopoldstraße 5, 80802, Munich, Germany

    K.-H. Herbinger, E. Fleischmann, C. Weber, P. Perona, T. Löscher & G. Bretzel

Authors
  1. K.-H. Herbinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Fleischmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Weber
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. Perona
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. T. Löscher
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G. Bretzel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K.-H. Herbinger.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Herbinger, KH., Fleischmann, E., Weber, C. et al. Epidemiological, clinical, and diagnostic data on intestinal infections with Entamoeba histolytica and Entamoeba dispar among returning travelers. Infection 39, 527–535 (2011). https://doi.org/10.1007/s15010-011-0155-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15010-011-0155-z

Keywords

Search

Navigation